-
Article | 2020.07.07
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
COVID-19: mathematical model indicates that between 3% and 7% of French people have been infected
-
Article | 2020.07.07
COVID-19 - The Bioinformatics and Biostatistics Hub on the front line
COVID-19 - The Bioinformatics and Biostatistics Hub on the front line
-
News | 2020.07.09
Sleeping sickness: one step further in improving diagnosis
The African trypanosome Trypanosoma brucei gambiense is a parasite responsible for chronic Human African Trypanosomiasis, more commonly known as sleeping sickness. Diagnosing sleeping sickness generally involves two stages: serological screening (to search for antibodies against parasites in the bloodstream), followed by the microscopic detection of live parasites in the blood or a lymph node...
-
Document de presse | 2020.07.06
COVID-19: no cross-protective immunity conferred by other coronaviruses in children
Every winter, seasonal coronaviruses are responsible for repeated colds and bronchitis from early childhood onwards. The question of whether the four seasonal coronaviruses can confer cross-protective immunity for COVID-19 was recently raised when it was demonstrated that some individuals had antibodies and immunity cells recognizing the SARS-CoV-2 virus before it was in active circulation. The...
-
Document de presse | 2020.07.15
Type 1 Interferon deficiency: A blood based Signature for Detecting Patients at risk of severe Covid-19 for a therapeutic approach
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of patients. In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting...
-
News | 2020.07.24
Viral sequence integrated in mosquito genome controls infection by related virus
A new endogenous viral element (EVE) has been identified in Aedes aegypti mosquitoes. This EVE is almost identical to a contemporaneous strain of cell-fusing agent virus (CFAV), a widespread insect-specific virus found in Ae. aegypti populations. Researchers experimentally demonstrated that this EVE controls CFAV replication in the mosquito’s ovaries. This discovery supports the idea that EVEs...
-
Page avancée | 2020.07.27
Innovation
The Institut Pasteur, a private and non-profit foundation, is a place where both basic research programs and technology transfer are supported in order to fulfill our four missions : research, public health, education and the identification of research applications. The Institut Pasteur is in a unique position to develop partnerships with industry to face public health challenges and...
-
Article | 2020.07.27
The Institut Pasteur is a private, non-profit foundation
The Institut Pasteur is ideally placed to successfully pursue its primary missions of research, public health, education and the identification of research applications. Its many strengths include the outstanding quality of its staff, the excellence of its research and infrastructures, and the critical mass of the Institut Pasteur International Network.The Technology Transfer and Industrial...
-
Article | 2020.07.27
Our mission
Our missionThe Institut Pasteur Technology Transfer and Industrial Partnership Department has generated close to 700 million euros in revenue over the last 15 years.The aim is to boost an open approach to future industry partners, from startups to major groups, to adapt more efficiently to the current and future requirements of society.The Technology Transfer and Industrial Partnership Department...
-
Article | 2020.07.27
Our Organization
The Technology Transfer and Industrial Partnership Department is responsible for the Institut Pasteur’s fourth mission – innovation development and technology transfer. Its role is to support the entire innovation process: identification of potential applications, protection, innovation development, promotion, transfer, and post-contract management. The aim is to bring medical solutions and...
